Is Matrixyl FDA approved?
No. This profile records Matrixyl as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE WRINKLE ERASER
Palmitoyl Pentapeptide-4 (Pal-KTTKS)
Matrixyl is a cosmetic peptide that mimics the fragments your skin produces when collagen breaks down. These "matrikine" signals tell your skin cells (fibroblasts) to produce more collagen, elastin, and hyaluronic acid. It's one of the most clinically-studied anti-wrinkle peptides and is found in many premium skincare products.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
May 8, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Matrixyl as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 0.5-2% concentration in topical products, applied twice daily.
Schedule: daily. Cycle: Ongoing daily use. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Signals fibroblasts to produce new collagen
Increases elastin synthesis for skin elasticity
Enhances hyaluronic acid and GAG production
Mimics wound-healing signals to rebuild skin matrix
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.